Treating non-ulcer dyspepsia and H pylori.
作者信息
van Zanten S J
出版信息
BMJ. 2000 Sep 16;321(7262):648-9. doi: 10.1136/bmj.321.7262.648.
Abstract
摘要
相似文献
1
Treating non-ulcer dyspepsia and H pylori.
BMJ. 2000 Sep 16;321(7262):648-9. doi: 10.1136/bmj.321.7262.648.
2
[Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
Gastroenterol Hepatol. 2000 Feb;23 Suppl 2:43-6.
3
Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective.
BMJ. 2001 Mar 3;322(7285):557.
4
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Aliment Pharmacol Ther. 2002 Aug;16(8):1491-501. doi: 10.1046/j.1365-2036.2002.01306.x.
5
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.
BMJ. 2000 Sep 16;321(7262):659-64. doi: 10.1136/bmj.321.7262.659.
6
Protagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia?
Gut. 2001 Jun;48(6):759-61. doi: 10.1136/gut.48.6.759.
7
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Aliment Pharmacol Ther. 2002 Mar;16(3):559-68. doi: 10.1046/j.1365-2036.2002.01204.x.
8
H. pylori and nonulcer dyspepsia: not guilty as charged.
Gastroenterology. 1999 Jul;117(1):270-2. doi: 10.1016/s0016-5085(99)70579-2.
9
Should H. pylori be eradicated in non-ulcer dyspepsia?
Drug Ther Bull. 2002 Mar;40(3):23-4. doi: 10.1136/dtb.2002.40323.
10
Treatment of Helicobacter pylori infection in functional dyspepsia.
J Fam Pract. 1999 Jul;48(7):496-7.
引用本文的文献
1
Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biased.
BMJ. 2002 Feb 23;324(7335):485-6.
本文引用的文献
1
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.
BMJ. 2000 Sep 16;321(7262):659-64. doi: 10.1136/bmj.321.7262.659.
2
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
CMAJ. 2000 Jun 13;162(12 Suppl):S3-23.
3
Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
Can J Gastroenterol. 2000 May;14(5):379-88. doi: 10.1155/2000/978035.
4
Functional gastroduodenal disorders.
Gut. 1999 Sep;45 Suppl 2(Suppl 2):II37-42. doi: 10.1136/gut.45.2008.ii37.
5
Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology.
Can J Gastroenterol. 1998 Jan-Feb;12(1):31-41. doi: 10.1155/1998/170180.
6
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.
Gastroenterology. 1998 Mar;114(3):582-95. doi: 10.1016/s0016-5085(98)70542-6.
7
What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.
Gastroenterology. 1997 Dec;113(6 Suppl):S67-77. doi: 10.1016/s0016-5085(97)80016-9.
8
Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
Ann Intern Med. 1997 Feb 15;126(4):280-91. doi: 10.7326/0003-4819-126-4-199702150-00004.
9
Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Am J Gastroenterol. 1996 Sep;91(9):1773-7.
10
Helicobacter pylori infection and dyspepsia.
Scand J Gastroenterol Suppl. 1996;215:38-47.
Zotero 插件